MedPath

Carbon Fiber Transpedicular Screws in Treatment of Spinal Metastatic Disease

Not Applicable
Recruiting
Conditions
Metastasis Spine
Metastatic Spinal Cord Compression
Interventions
Procedure: Transpedicular spinal stabilization - titanium implants
Procedure: Transpedicular spinal stabilization - carbon fibers-based implants
Radiation: Stereotactic body radiotherapy
Registration Number
NCT06293157
Lead Sponsor
Copernicus Memorial Hospital
Brief Summary

Background: Spinal metastatic disease constitute a serious clinical problem in oncology. Bones are the third most common organ where metastases are located, and the spine is the place where they are most often located. Due to the complexity of the clinical problem, metastatic spine disease remains of interest to many medical specialties: neurosurgery, orthopedics, clinical oncology, radiotherapy and rehabilitation. With the development of modern diagnostic methods and wider access to them, the demand for neurosurgical treatment in this group of patients is growing. Surgical treatment is undertaken in cases of spinal cord compression, instability, spinal deformation or pain that is resistant to radiotherapy. The standard treatment in most cases is posterior instrumentation of the spine using titanium pedicle screws. Unfortunately, these systems cause numerous artifacts in diagnostic imaging, both in CT and MRI. These distortions make it difficult to plan radiotherapy and determine the optimal dose that would avoid healthy tissues. Moreover, artifacts could make difficult postoperative follow-ups aimed at assessing local recurrence. The solution to these problems is the use of radiolucent implants. There are systems based on carbon fibers embedded in PEEK which do not cause typical artifacts for titanium implants.

Study plan: The open, three-arm, prospective randomized study is planned to involve 226 patients with metastatic disease of the spine, with a known or undiagnosed primary site. Patients will be qualified for 2 types of interventions. The first one includes treatment with stereotactic radiotherapy (SBRT) in the first stage of treatment and early instrumentation of the spine with titanium implants. The second type of intervention includes patients qualified for surgical treatment using spine stabilization and postoperative SBRT. Patients within this arm will be randomized into two groups differing in the type of material the instrumentation is made of: carbon-PEEK or titanium. The study group will be patients stabilized with carbon implants, and the control group will be those who will have titanium implants.

Study population: The study includes adult patients with metastatic spine disease, with a known or unknown primary tumor, qualified for SBRT and surgical treatment.

Assumed effects: It is assumed that the treatment proposed in the project would extend progression free survival by several months or achieve local control in an additional 5% of patients. Moreover, by improving the quality of imaging, earlier diagnosis of local recurrences and implementation of appropriate locoregional treatment would be possible.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
226
Inclusion Criteria
  • Metastatic spinal disease,
  • ECOG quality of life of 0-2,
  • Eligibility for SBRT treatment,
  • Expected survival time >3 months,
  • Signed informed consent to participate in the study,
  • Sufficient organ capacity allowing to survive the perioperative period.
Exclusion Criteria
  • Primary tumor of the spine,
  • Age <18 years old,
  • Expected survival time <3 months,
  • Eligibility for palliative radiotherapy,
  • No informed consent to participate in the study,
  • Pregnancy or breastfeeding,
  • The advancement of the disease preventing the technical use of implants.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Transpedicular spinal stabilization using titanium system + SBRTTranspedicular spinal stabilization - titanium implantsTranspedicular spinal stabilization using a titanium system followed by stereotactic radiotherapy of the spine at a dose of 5x5 Gy (25 Gy in the total dose)
Transpedicular spinal stabilization using carbon system + SBRTTranspedicular spinal stabilization - carbon fibers-based implantsTranspedicular spinal stabilization using a radiolucent composite system made of carbon fibers and PEEK followed by stereotactic radiotherapy of the spine at a dose of 5x5 Gy (25 Gy in the total dose)
Transpedicular spinal stabilization using carbon system + SBRTStereotactic body radiotherapyTranspedicular spinal stabilization using a radiolucent composite system made of carbon fibers and PEEK followed by stereotactic radiotherapy of the spine at a dose of 5x5 Gy (25 Gy in the total dose)
Transpedicular spinal stabilization using titanium system + SBRTStereotactic body radiotherapyTranspedicular spinal stabilization using a titanium system followed by stereotactic radiotherapy of the spine at a dose of 5x5 Gy (25 Gy in the total dose)
SBRT + Transpedicular spinal stabilization using titanium systemStereotactic body radiotherapyTranspedicular spinal stabilization using a titanium system preceded with stereotactic spine radiotherapy at a dose of 5x5 Gy (25 Gy in the total dose) as the first stage of treatment
SBRT + Transpedicular spinal stabilization using titanium systemTranspedicular spinal stabilization - titanium implantsTranspedicular spinal stabilization using a titanium system preceded with stereotactic spine radiotherapy at a dose of 5x5 Gy (25 Gy in the total dose) as the first stage of treatment
Primary Outcome Measures
NameTimeMethod
The assessment of time to local recurrence after treatment with SBRT.5 years
The assessment of frequency of local recurrence after treatment with SBRT.5 years
Secondary Outcome Measures
NameTimeMethod
Differences in dosimetric parameter D98.1 day
Differences in dosimetric parameter D95.1 day
The frequency of radiation complications assessed according to the National Cancer Institute Common Toxicity Criteria (NCI CTC).5 years

Titanium instrumentation generates significant artifacts in radiological imaging used for radiotherapy planning. The use of opaque, radiolucent material allows for radiotherapy planning to cover a smaller area. This may reduce the incidence of radiation-related complications in nearby organs (OAR - organ at risk). These complications will be assessed by the radiation therapist according to the standardized NCI CTC scale. Potentially smaller quantity of organ complications could be an advantage supporting the use of carbon implants.

Failure rate of stabilizing systems.5 years

Titanium and carbon fiber show similar biocompatibility. The biomechanical properties of these materials are also similar. In vitro studies have shown a similar effect failure rate of carbon pedicle screws compared to standard titanium ones. However, carbon rods have greater flexibility and structure connected using these may show more frequent loosening in vivo, especially in cases with impaired sagittal balance. This was not an issue analyzed in the literature. The frequency of instrument failure is of great importance for clinical practice because most such cases require operative revision.

Frequency of postoperative infections.5 years

Postoperative wound infections are an inherent complication of surgical procedures. The longer the procedure, the more often inflammatory complications are observed, especially in oncological population, which has a higher average age of treated patients, a greater number of burdens, frequent immunosuppression due to systemic treatment, and malnutrition in the form of decreased biochemical parameters (total protein and albumin). Titanium has good properties in this aspect. Bacterial biofilms, is rarely formed on it, which means that patients can be treated more often without the need to remove the implants. It is unclear how carbon fiber system will perform in these cases. There are not made of metal, but of carbon fiber embedded in polymer. Assessment of the frequency of inflammatory complications and their course will provide the answer to whether This instrumentation allows for a similar management strategy in clinical settings.

Differences in dosimetric parameter conformity index (CI) / homogeneity index (HI)).1 day
DICE convergence factor evaluation between groups of patients.1 day

The use of convergence factor assessment will allow for comparison of similarity in planned SBRT between all groups. This will allow an indirect assessment of difficulties in planning treatment by a radiotherapist using objective tools.

The subjective difficulty of planning radiotherapy treatment.1 day

Using a numerical scale from 0-10, the radiotherapist will assess the difficulty of planning, tumor coverage, and delineation of the spinal cord depending on the group assessed in the study.

Pain assessment on the VAS scale between groups.5 years

One of the goals of surgical treatment is to treat mechanical pain caused by segmental instability. SBRT is a good method of treating biological pain. There are no comparisons of analgesic effects between transpedicular systems. Greater pain reduction allows for more effective and longer ability to walk, lower consumption of painkillers, and lower incidence of complications related to immobilization (thrombosis, bedsores, respiratory infections), which also has pharmacoeconomic implications.

Differences in dosimetric parameter Dmin PTV/CTV.1 day
Differences in dosimetric parameter D100.1 day

Trial Locations

Locations (1)

Copernicus Memorial Hospital in Łódź, Poland

🇵🇱

Łódź, Łódzkie, Poland

© Copyright 2025. All Rights Reserved by MedPath